IP Library Granted Patent US 8,188,111
Granted Patent B2
US 8,188,111 · App. 11/991,686 · Granted May 29, 2012

Amide and carbamate derivatives of alkyl substituted

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,188,111
App. No.
11/991,686
Granted
May 29, 2012
Kind
B2
Abstract

Amide and carbamate derivatives of N-[4-(4-amino-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamides with an ethyl, methyl, or n-propyl substituent at the 2-position, pharmaceutical compositions containing these compounds, methods of making the compounds, and methods of use of these compounds in modulating the immune system, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

Claims (19)

1. A compound of the Formula I

wherein:

Y is selected from the group consisting of —C(O)— and —C(O)—O—;

R is selected from the group consisting of alkyl, aryl, and arylalkylenyl; wherein aryl and arylalkylenyl are unsubstituted or substituted by one or more substituents selected from the group consisting of alkyl, alkoxy, aryl, and halogen; and

R′ is selected from the group consisting of methyl, ethyl, and n-propyl;

or a pharmaceutically acceptable salt thereof.

2. The compound or salt of claim 1 wherein Y is —C(O)—.

3. The compound or salt of claim 1 wherein Y is —C(O)—O—.

4. The compound or salt of claim 1 wherein R is C 1-10 alkyl.

5. The compound or salt of claim 1 wherein R is C 1-5 alkyl.

6. The compound or salt of claim 1 wherein R is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, and tert-butyl.

7. The compound or salt of claim 1 wherein R is aryl.

8. The compound or salt of claim 1 wherein R is phenyl.

9. The compound or salt of claim 1 wherein R is arylalkylenyl.

10. The compound or salt of claim 1 wherein R is benzyl.

11. The compound or salt of claim 1 wherein R′ is ethyl.

12. The compound or salt of claim 1 wherein R′ is methyl.

13. The compound or salt of claim 1 wherein R′ is n-propyl.

14. A pharmaceutical composition comprising a therapeutically effective amount of a compound or salt of claim 1 and a pharmaceutically acceptable carrier.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2011
From: COLEY PHARMACEUTICAL GROUP, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 025839/0772 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2009
From: 3M INNOVATIVE PROPERTIES COMPANY & 3M COMPANY
To: COLEY PHARMACEUTICAL GROUP, INC.
Reel/Frame 022153/0255 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2009
From: KSHIRSAGAR, TUSHAR A.; NIWAS, SHRI; MERRILL, BYRON A.
To: 3M INNOVATIVE PROPERTIES COMPANY & 3M COMPANY
Reel/Frame 022089/0233 →